MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
Clinical trial NCT04646603 · UNKNOWN
Trial details
- NCT number
- NCT04646603
- Sponsor
- MedRegen LLC
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-03-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.